The satellite radio's Sirius Travel Link, in addition to traffic and weather reports, can call up real-time pump prices at gas stations and movie showtimes at theaters.
In this study, we apply artificial intelligence techniques to the development of two real-time pumping station operation models, namely, a historical and an optimized adaptive network-based fuzzy inference system (ANFIS-His and ANFIS-Opt, respectively).
Also since 2010, all children were transferred to real time insulin pumps; therefore at the moment of observation, they all used the same type of pump from the same manufacturer.
This work reports the design of the controller which, via a feedback loop, varies and controls the pump rate in real time by automatically adjusting the pump power to precisely modulate the emission of 550nm in Er3+-doped Fluoroindate glass under 1.48μm pumping.
In this trial we randomly initiated pump therapy in patients with insufficient metabolic control despite optimized basal-bolus injection regimens with either the MiniMed Paradigm REAL-Time insulin pump (PRT), an insulin pump that can receive and display CGM data from a separate subcutaneous glucose sensor, or conventional CSII, and compared glycemic outcomes after 6 months.
Subjects assigned to the CGM group were provided with one of the following devices: the DexCom SEVEN (DexCom, San Diego, CA), the MiniMed Paradigm REAL-Time Insulin Pump and Continuous Glucose Monitoring System (Medtronic MiniMed, Northridge, CA), or the FreeStyle Navigator (Abbott Diabetes Care, Alameda, CA).
Subjects received one of the following CGM devices: the DexCom SEVEN (DexCom, San Diego, CA), the MiniMed Paradigm REAL-Time insulin pump and continuous glucose monitoring system (Medtronic MiniMed, Northridge, CA), or the FreeStyle Navigator (Abbott Diabetes Care, Alameda, CA).
The dataset used for the current analyses included 180 subjects assigned to the CGM group who used either the FreeStyle Navigator (Abbott Diabetes Care, Alameda, CA) or the MiniMed Paradigm REAL-Time Insulin Pump and Continuous Glucose Monitoring System (Medtronic MiniMed, Northridge, CA).
After completion of the 6-month outcome of the randomized trial, each control group subject was provided with one of the following CGM devices: the DexCom SEVEN (DexCom, San Diego, CA), the MiniMed Paradigm REAL-Time Insulin Pump and Continuous Glucose Monitoring System (Medtronic MiniMed, Northridge, CA), or the FreeStyle Navigator (Abbott Diabetes Care, Alameda, CA).
The key point of this detection system is to have two pulsed coherent lights with same frequency, same polarization and same initial phase, of which one beam is taken as the detection wave for generating stimulated Brillouin scattering signal and the other beam is taken as pumping wave for real time and effective amplification of stimulated Brillouin scattering signal.
During both overnight studies, closed-loop achieved significantly better glucose control than standard insulin pump therapy combined with real time CGM without increasing the risk of hypoglycaemia 29 30 or negatively impacting quality of life or psychosocial functioning.
